NCT03918993 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Cimen S, Dursun M, Sulukaya M, Besiroglu H
Could the monocyte/HDL cholesterol ratio be an early marker of erectile dysfunction? Aging Male. 2019 Feb 19:1-6. doi: 10.1080/13685538.2019.1574735. [Epub ahead of print]
Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL
The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011 Nov 14;171(20):1797-803. doi
Kadihasanoglu M, Karabay E, Yucetas U, Erkan E, Ozbek E
Relation between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Presence and Severity of Erectile Dysfunction. Aktuelle Urol. 2018 Jun;49(3):256-261. doi: 10.1055/s-0042-123163. Epub 201

Evaluation of the Effects of a Daily Dose of 5 mg of Tadalafil on Lymphocyte to Monocyte Ratio and Monocyte to High-Density Lipoprotein Ratio in Patients With Erectile Dysfunction

Details for clinical trial NCT03918993

Clinical trial NCT03918993 - References